The successful return of psychedelics to psychiatry

Abstract

Get full access to this article

View all access options for this article.

References

Griffiths

Johnson

Carducci

. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 30: 1181-1197

Ross

Bossis

Guss

. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30: 1165-1180.